Article

A collaborative effort: Needle revision for failed bleb helped by preoperative MMC

Glaucoma researchers at Pusan University Medical Center, Pusan, South Korea and the Kresge Eye Institute (KEI) of Wayne State University, Detroit, MI, working in collaboration, have found that the preoperative injection of mitomycin-C (MMC) can be an effective and safe adjunct to a needling revision procedure for a failed bleb.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.